Benjamin F. Edwards & Company, Inc. Jazz Pharmaceuticals PLC Transaction History

Benjamin F. Edwards & Company, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$128.64 - $184.79 $50,298 - $72,252	-391 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$160.2 - $186.42 $15,058 - $17,523	94 Added 31.65%	391 $69,000
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $10,062 - $11,624	67 Added 29.13%	297 $49,000
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $2,673 - $3,135	-19 Reduced 7.63%	230 $38,000
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $5,800 - $7,927	-55 Reduced 18.09%	249 $36,000
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $8,324 - $10,603	87 Added 40.09%	304 $34,000
Q1 2020 May 07, 2020	SELL	$87.74 - $152.74 $6,755 - $11,760	-77 Reduced 26.19%	217 $22,000
Q4 2019 Feb 06, 2020	SELL	$117.65 - $153.73 $83,060 - $108,533	-706 Reduced 70.6%	294 $44,000
Q3 2019 Nov 05, 2019	BUY	$125.18 - $143.24 $125,180 - $143,240	1,000 New	1,000 $128,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $1,339 - $1,572	-11 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$115.94 - $166.74 $1,275 - $1,834	11 New	11 $1,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.